nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—Pruritus generalised—Octreotide—thymus cancer	0.0356	0.142	CcSEcCtD
Afatinib—BLK—hematopoietic system—thymus cancer	0.019	0.055	CbGeAlD
Afatinib—ERBB2—neck—thymus cancer	0.0175	0.0506	CbGeAlD
Afatinib—BLK—lymphoid tissue—thymus cancer	0.0134	0.0387	CbGeAlD
Afatinib—ERBB2—hematopoietic system—thymus cancer	0.013	0.0377	CbGeAlD
Afatinib—DYRK1A—hematopoietic system—thymus cancer	0.0125	0.0363	CbGeAlD
Afatinib—ERBB2—epithelium—thymus cancer	0.0119	0.0344	CbGeAlD
Afatinib—ERBB4—epithelium—thymus cancer	0.0119	0.0344	CbGeAlD
Afatinib—Cystitis noninfective—Octreotide—thymus cancer	0.0116	0.0462	CcSEcCtD
Afatinib—Cystitis—Octreotide—thymus cancer	0.0115	0.0457	CcSEcCtD
Afatinib—Mouth ulceration—Octreotide—thymus cancer	0.0107	0.0428	CcSEcCtD
Afatinib—Bladder pain—Octreotide—thymus cancer	0.0107	0.0428	CcSEcCtD
Afatinib—ERBB4—cardiac atrium—thymus cancer	0.00988	0.0286	CbGeAlD
Afatinib—IRAK1—hematopoietic system—thymus cancer	0.00973	0.0282	CbGeAlD
Afatinib—ERBB4—pituitary gland—thymus cancer	0.00965	0.0279	CbGeAlD
Afatinib—PHKG2—thyroid gland—thymus cancer	0.00925	0.0268	CbGeAlD
Afatinib—ERBB2—lymphoid tissue—thymus cancer	0.00916	0.0265	CbGeAlD
Afatinib—DYRK1A—lymphoid tissue—thymus cancer	0.00881	0.0255	CbGeAlD
Afatinib—PHKG2—lung—thymus cancer	0.0084	0.0243	CbGeAlD
Afatinib—ERBB4—thyroid gland—thymus cancer	0.00832	0.0241	CbGeAlD
Afatinib—ERBB2—thyroid gland—thymus cancer	0.00832	0.0241	CbGeAlD
Afatinib—Dehydration—Octreotide—thymus cancer	0.00802	0.032	CcSEcCtD
Afatinib—DYRK1A—thyroid gland—thymus cancer	0.00801	0.0232	CbGeAlD
Afatinib—Dry skin—Octreotide—thymus cancer	0.00791	0.0315	CcSEcCtD
Afatinib—Nasopharyngitis—Octreotide—thymus cancer	0.00771	0.0307	CcSEcCtD
Afatinib—ERBB2—lung—thymus cancer	0.00755	0.0219	CbGeAlD
Afatinib—ERBB4—lung—thymus cancer	0.00755	0.0219	CbGeAlD
Afatinib—BLK—lymph node—thymus cancer	0.00754	0.0218	CbGeAlD
Afatinib—DYRK1A—lung—thymus cancer	0.00727	0.0211	CbGeAlD
Afatinib—EGFR—thyroid gland—thymus cancer	0.00705	0.0204	CbGeAlD
Afatinib—Upper respiratory tract infection—Octreotide—thymus cancer	0.00693	0.0276	CcSEcCtD
Afatinib—Weight decreased—Octreotide—thymus cancer	0.00675	0.0269	CcSEcCtD
Afatinib—Pneumonia—Octreotide—thymus cancer	0.00669	0.0266	CcSEcCtD
Afatinib—Urinary tract infection—Octreotide—thymus cancer	0.00646	0.0257	CcSEcCtD
Afatinib—Conjunctivitis—Octreotide—thymus cancer	0.00646	0.0257	CcSEcCtD
Afatinib—EGFR—lung—thymus cancer	0.0064	0.0185	CbGeAlD
Afatinib—Hepatobiliary disease—Octreotide—thymus cancer	0.00629	0.025	CcSEcCtD
Afatinib—Epistaxis—Octreotide—thymus cancer	0.00627	0.025	CcSEcCtD
Afatinib—IRAK1—bone marrow—thymus cancer	0.00624	0.0181	CbGeAlD
Afatinib—IRAK1—thyroid gland—thymus cancer	0.00622	0.018	CbGeAlD
Afatinib—LCK—bone marrow—thymus cancer	0.00608	0.0176	CbGeAlD
Afatinib—LCK—thyroid gland—thymus cancer	0.00607	0.0176	CbGeAlD
Afatinib—PHKG2—lymph node—thymus cancer	0.00575	0.0166	CbGeAlD
Afatinib—IRAK1—lung—thymus cancer	0.00565	0.0164	CbGeAlD
Afatinib—LCK—lung—thymus cancer	0.00551	0.016	CbGeAlD
Afatinib—ABL1—hematopoietic system—thymus cancer	0.00545	0.0158	CbGeAlD
Afatinib—Alopecia—Octreotide—thymus cancer	0.00527	0.021	CcSEcCtD
Afatinib—Mental disorder—Octreotide—thymus cancer	0.00523	0.0208	CcSEcCtD
Afatinib—Malnutrition—Octreotide—thymus cancer	0.0052	0.0207	CcSEcCtD
Afatinib—ERBB2—lymph node—thymus cancer	0.00517	0.015	CbGeAlD
Afatinib—Back pain—Octreotide—thymus cancer	0.00503	0.02	CcSEcCtD
Afatinib—Muscle spasms—Octreotide—thymus cancer	0.00499	0.0199	CcSEcCtD
Afatinib—DYRK1A—lymph node—thymus cancer	0.00497	0.0144	CbGeAlD
Afatinib—Cough—Octreotide—thymus cancer	0.00453	0.0181	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00439	0.0175	CcSEcCtD
Afatinib—EGFR—lymph node—thymus cancer	0.00438	0.0127	CbGeAlD
Afatinib—Infection—Octreotide—thymus cancer	0.00421	0.0168	CcSEcCtD
Afatinib—Nervous system disorder—Octreotide—thymus cancer	0.00416	0.0166	CcSEcCtD
Afatinib—ABL1—cardiac atrium—thymus cancer	0.00414	0.012	CbGeAlD
Afatinib—Skin disorder—Octreotide—thymus cancer	0.00412	0.0164	CcSEcCtD
Afatinib—ABL1—pituitary gland—thymus cancer	0.00404	0.0117	CbGeAlD
Afatinib—IRAK1—lymph node—thymus cancer	0.00386	0.0112	CbGeAlD
Afatinib—ABL1—lymphoid tissue—thymus cancer	0.00384	0.0111	CbGeAlD
Afatinib—Insomnia—Octreotide—thymus cancer	0.00383	0.0153	CcSEcCtD
Afatinib—Dyspnoea—Octreotide—thymus cancer	0.00378	0.0151	CcSEcCtD
Afatinib—LCK—lymph node—thymus cancer	0.00377	0.0109	CbGeAlD
Afatinib—Dyspepsia—Octreotide—thymus cancer	0.00373	0.0149	CcSEcCtD
Afatinib—Decreased appetite—Octreotide—thymus cancer	0.00369	0.0147	CcSEcCtD
Afatinib—Gastrointestinal disorder—Octreotide—thymus cancer	0.00366	0.0146	CcSEcCtD
Afatinib—Fatigue—Octreotide—thymus cancer	0.00366	0.0146	CcSEcCtD
Afatinib—Constipation—Octreotide—thymus cancer	0.00363	0.0144	CcSEcCtD
Afatinib—ABL1—bone marrow—thymus cancer	0.00349	0.0101	CbGeAlD
Afatinib—ABL1—thyroid gland—thymus cancer	0.00348	0.0101	CbGeAlD
Afatinib—Body temperature increased—Octreotide—thymus cancer	0.00335	0.0133	CcSEcCtD
Afatinib—ABL1—lung—thymus cancer	0.00317	0.00917	CbGeAlD
Afatinib—Asthenia—Octreotide—thymus cancer	0.00304	0.0121	CcSEcCtD
Afatinib—Pruritus—Octreotide—thymus cancer	0.003	0.0119	CcSEcCtD
Afatinib—Diarrhoea—Octreotide—thymus cancer	0.0029	0.0116	CcSEcCtD
Afatinib—Dizziness—Octreotide—thymus cancer	0.0028	0.0112	CcSEcCtD
Afatinib—Vomiting—Octreotide—thymus cancer	0.0027	0.0107	CcSEcCtD
Afatinib—Rash—Octreotide—thymus cancer	0.00267	0.0106	CcSEcCtD
Afatinib—Dermatitis—Octreotide—thymus cancer	0.00267	0.0106	CcSEcCtD
Afatinib—Headache—Octreotide—thymus cancer	0.00266	0.0106	CcSEcCtD
Afatinib—ABCG2—pituitary gland—thymus cancer	0.00255	0.00738	CbGeAlD
Afatinib—Nausea—Octreotide—thymus cancer	0.00252	0.01	CcSEcCtD
Afatinib—ABCG2—bone marrow—thymus cancer	0.0022	0.00638	CbGeAlD
Afatinib—ABCG2—thyroid gland—thymus cancer	0.0022	0.00636	CbGeAlD
Afatinib—ABL1—lymph node—thymus cancer	0.00216	0.00627	CbGeAlD
Afatinib—ABCG2—lung—thymus cancer	0.002	0.00578	CbGeAlD
Afatinib—ABCB1—hematopoietic system—thymus cancer	0.00169	0.00491	CbGeAlD
Afatinib—ABCB1—epithelium—thymus cancer	0.00155	0.00449	CbGeAlD
Afatinib—ABCG2—lymph node—thymus cancer	0.00137	0.00395	CbGeAlD
Afatinib—ABCB1—pituitary gland—thymus cancer	0.00126	0.00364	CbGeAlD
Afatinib—ABCB1—lymphoid tissue—thymus cancer	0.00119	0.00346	CbGeAlD
Afatinib—ABCB1—bone marrow—thymus cancer	0.00109	0.00315	CbGeAlD
Afatinib—ABCB1—thyroid gland—thymus cancer	0.00108	0.00314	CbGeAlD
Afatinib—ABCB1—lung—thymus cancer	0.000984	0.00285	CbGeAlD
Afatinib—ABCB1—lymph node—thymus cancer	0.000673	0.00195	CbGeAlD
Afatinib—ERBB2—Signaling by FGFR—AKT1—thymus cancer	0.000482	0.00119	CbGpPWpGaD
Afatinib—ERBB2—EGF/EGFR Signaling Pathway—AKT1—thymus cancer	0.000482	0.00119	CbGpPWpGaD
Afatinib—ERBB2—Signaling by ERBB2—AKT1—thymus cancer	0.000479	0.00119	CbGpPWpGaD
Afatinib—EGFR—AGE/RAGE pathway—AKT1—thymus cancer	0.000478	0.00118	CbGpPWpGaD
Afatinib—ERBB2—DAP12 signaling—AKT1—thymus cancer	0.000477	0.00118	CbGpPWpGaD
Afatinib—ERBB4—Downstream signal transduction—AKT1—thymus cancer	0.000477	0.00118	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways in Glioblastoma—TP53—thymus cancer	0.000475	0.00118	CbGpPWpGaD
Afatinib—ERBB4—Signaling by FGFR—AKT1—thymus cancer	0.000475	0.00118	CbGpPWpGaD
Afatinib—ERBB4—Signaling by ERBB2—AKT1—thymus cancer	0.000472	0.00117	CbGpPWpGaD
Afatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—AKT1—thymus cancer	0.000472	0.00117	CbGpPWpGaD
Afatinib—ERBB2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	0.00047	0.00116	CbGpPWpGaD
Afatinib—ERBB4—DAP12 signaling—AKT1—thymus cancer	0.00047	0.00116	CbGpPWpGaD
Afatinib—ABL1—Cell Cycle—TP53—thymus cancer	0.000467	0.00116	CbGpPWpGaD
Afatinib—EGFR—Regulation of Telomerase—AKT1—thymus cancer	0.000466	0.00116	CbGpPWpGaD
Afatinib—ERBB4—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	0.000463	0.00115	CbGpPWpGaD
Afatinib—LCK—TCR signaling in naïve CD4+ T cells—AKT1—thymus cancer	0.00046	0.00114	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—KIT—thymus cancer	0.000457	0.00113	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—KIT—thymus cancer	0.00045	0.00112	CbGpPWpGaD
Afatinib—LCK—Costimulation by the CD28 family—AKT1—thymus cancer	0.000449	0.00111	CbGpPWpGaD
Afatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000449	0.00111	CbGpPWpGaD
Afatinib—ERBB2—DAP12 interactions—AKT1—thymus cancer	0.000449	0.00111	CbGpPWpGaD
Afatinib—ERBB2—Signaling by FGFR in disease—AKT1—thymus cancer	0.000449	0.00111	CbGpPWpGaD
Afatinib—ABCG2—HIF-1-alpha transcription factor network—AKT1—thymus cancer	0.000446	0.0011	CbGpPWpGaD
Afatinib—ERBB2—Signaling by EGFR—AKT1—thymus cancer	0.000445	0.0011	CbGpPWpGaD
Afatinib—ABL1—DNA Damage Response (only ATM dependent)—TP53—thymus cancer	0.000443	0.0011	CbGpPWpGaD
Afatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000442	0.0011	CbGpPWpGaD
Afatinib—ERBB4—DAP12 interactions—AKT1—thymus cancer	0.000442	0.0011	CbGpPWpGaD
Afatinib—ERBB4—Signaling by FGFR in disease—AKT1—thymus cancer	0.000442	0.0011	CbGpPWpGaD
Afatinib—ERBB2—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.000441	0.00109	CbGpPWpGaD
Afatinib—ERBB2—Signaling by PDGF—AKT1—thymus cancer	0.000439	0.00109	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—KIT—thymus cancer	0.000439	0.00109	CbGpPWpGaD
Afatinib—ERBB4—Signaling by EGFR—AKT1—thymus cancer	0.000438	0.00109	CbGpPWpGaD
Afatinib—DYRK1A—Cell Cycle—TP53—thymus cancer	0.000437	0.00108	CbGpPWpGaD
Afatinib—ERBB4—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.000434	0.00108	CbGpPWpGaD
Afatinib—ERBB4—Signaling by PDGF—AKT1—thymus cancer	0.000432	0.00107	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—KIT—thymus cancer	0.000432	0.00107	CbGpPWpGaD
Afatinib—ERBB2—Focal Adhesion—AKT1—thymus cancer	0.000424	0.00105	CbGpPWpGaD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.000422	0.00105	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—KIT—thymus cancer	0.000416	0.00103	CbGpPWpGaD
Afatinib—ERBB2—B Cell Activation—AKT1—thymus cancer	0.000415	0.00103	CbGpPWpGaD
Afatinib—IRAK1—Cytokine Signaling in Immune system—IL2—thymus cancer	0.000415	0.00103	CbGpPWpGaD
Afatinib—ABL1—Immune System—CYLD—thymus cancer	0.000411	0.00102	CbGpPWpGaD
Afatinib—ERBB4—B Cell Activation—AKT1—thymus cancer	0.000409	0.00101	CbGpPWpGaD
Afatinib—BLK—Focal Adhesion—AKT1—thymus cancer	0.000402	0.000996	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways in Glioblastoma—AKT1—thymus cancer	0.000402	0.000995	CbGpPWpGaD
Afatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	0.000397	0.000985	CbGpPWpGaD
Afatinib—IRAK1—Regulation of toll-like receptor signaling pathway—AKT1—thymus cancer	0.000394	0.000975	CbGpPWpGaD
Afatinib—BLK—B Cell Activation—AKT1—thymus cancer	0.000394	0.000975	CbGpPWpGaD
Afatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	0.000392	0.00097	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—KIT—thymus cancer	0.000387	0.00096	CbGpPWpGaD
Afatinib—EGFR—Constitutive PI3K/AKT Signaling in Cancer—AKT1—thymus cancer	0.000387	0.000958	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—IL2—thymus cancer	0.000385	0.000954	CbGpPWpGaD
Afatinib—LCK—CXCR4-mediated signaling events—AKT1—thymus cancer	0.00038	0.00094	CbGpPWpGaD
Afatinib—PHKG2—Disease—CD4—thymus cancer	0.000379	0.000939	CbGpPWpGaD
Afatinib—EGFR—Androgen receptor signaling pathway—AKT1—thymus cancer	0.000376	0.000932	CbGpPWpGaD
Afatinib—ABL1—DNA Damage Response (only ATM dependent)—AKT1—thymus cancer	0.000374	0.000927	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—KIT—thymus cancer	0.000373	0.000925	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—MAML2—thymus cancer	0.000373	0.000924	CbGpPWpGaD
Afatinib—LCK—Constitutive PI3K/AKT Signaling in Cancer—AKT1—thymus cancer	0.000372	0.000923	CbGpPWpGaD
Afatinib—ABL1—Factors involved in megakaryocyte development and platelet production—TP53—thymus cancer	0.000371	0.00092	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—MAML2—thymus cancer	0.000367	0.00091	CbGpPWpGaD
Afatinib—LCK—HIV Infection—CD4—thymus cancer	0.000357	0.000885	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—TP53—thymus cancer	0.000355	0.00088	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CD8A—thymus cancer	0.000354	0.000878	CbGpPWpGaD
Afatinib—EGFR—Immune System—CYLD—thymus cancer	0.000351	0.000869	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—CD4—thymus cancer	0.000349	0.000866	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CD8A—thymus cancer	0.000349	0.000865	CbGpPWpGaD
Afatinib—EGFR—PI-3K cascade—AKT1—thymus cancer	0.000348	0.000863	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—CD4—thymus cancer	0.000344	0.000853	CbGpPWpGaD
Afatinib—ABL1—Integrated Breast Cancer Pathway—TP53—thymus cancer	0.000341	0.000846	CbGpPWpGaD
Afatinib—EGFR—PI3K/AKT activation—AKT1—thymus cancer	0.00034	0.000842	CbGpPWpGaD
Afatinib—LCK—B Cell Receptor Signaling Pathway—AKT1—thymus cancer	0.000338	0.000838	CbGpPWpGaD
Afatinib—LCK—Immune System—CYLD—thymus cancer	0.000338	0.000838	CbGpPWpGaD
Afatinib—EGFR—GAB1 signalosome—AKT1—thymus cancer	0.000337	0.000835	CbGpPWpGaD
Afatinib—BLK—Immune System—CD8A—thymus cancer	0.000336	0.000832	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—CD4—thymus cancer	0.000336	0.000832	CbGpPWpGaD
Afatinib—LCK—PI-3K cascade—AKT1—thymus cancer	0.000336	0.000831	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—CD4—thymus cancer	0.000331	0.000819	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—KIT—thymus cancer	0.00033	0.000819	CbGpPWpGaD
Afatinib—EGFR—ErbB1 downstream signaling—AKT1—thymus cancer	0.000329	0.000816	CbGpPWpGaD
Afatinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—thymus cancer	0.000329	0.000816	CbGpPWpGaD
Afatinib—LCK—PI3K/AKT activation—AKT1—thymus cancer	0.000328	0.000811	CbGpPWpGaD
Afatinib—LCK—GAB1 signalosome—AKT1—thymus cancer	0.000325	0.000805	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—IL2—thymus cancer	0.000323	0.0008	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—CD4—thymus cancer	0.000318	0.000788	CbGpPWpGaD
Afatinib—LCK—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—thymus cancer	0.000317	0.000787	CbGpPWpGaD
Afatinib—EGFR—Direct p53 effectors—TP53—thymus cancer	0.00031	0.000768	CbGpPWpGaD
Afatinib—ERBB2—Signaling by NGF—AKT1—thymus cancer	0.000306	0.000757	CbGpPWpGaD
Afatinib—ERBB4—Signaling by NGF—AKT1—thymus cancer	0.000301	0.000746	CbGpPWpGaD
Afatinib—EGFR—Integrated Breast Cancer Pathway—TP53—thymus cancer	0.000292	0.000723	CbGpPWpGaD
Afatinib—ABL1—Integrated Breast Cancer Pathway—AKT1—thymus cancer	0.000288	0.000714	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.000283	0.000701	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD8A—thymus cancer	0.000282	0.0007	CbGpPWpGaD
Afatinib—ABL1—EGF/EGFR Signaling Pathway—AKT1—thymus cancer	0.000273	0.000675	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD8A—thymus cancer	0.000272	0.000674	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—MAML2—thymus cancer	0.000269	0.000668	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—TP53—thymus cancer	0.000268	0.000664	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—IL2—thymus cancer	0.000267	0.000662	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—AKT1—thymus cancer	0.000267	0.000661	CbGpPWpGaD
Afatinib—ERBB2—Immune System—KIT—thymus cancer	0.000266	0.000659	CbGpPWpGaD
Afatinib—ERBB4—Immune System—KIT—thymus cancer	0.000262	0.00065	CbGpPWpGaD
Afatinib—EGFR—Signaling by SCF-KIT—AKT1—thymus cancer	0.00026	0.000645	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—KIT—thymus cancer	0.000259	0.000641	CbGpPWpGaD
Afatinib—EGFR—Disease—MAML2—thymus cancer	0.000257	0.000638	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD8A—thymus cancer	0.000256	0.000635	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—CD4—thymus cancer	0.000253	0.000626	CbGpPWpGaD
Afatinib—BLK—Immune System—KIT—thymus cancer	0.000252	0.000625	CbGpPWpGaD
Afatinib—LCK—Signaling by SCF-KIT—AKT1—thymus cancer	0.000251	0.000621	CbGpPWpGaD
Afatinib—EGFR—Downstream signaling of activated FGFR—AKT1—thymus cancer	0.000249	0.000617	CbGpPWpGaD
Afatinib—LCK—Disease—MAML2—thymus cancer	0.000248	0.000614	CbGpPWpGaD
Afatinib—EGFR—Integrated Breast Cancer Pathway—AKT1—thymus cancer	0.000246	0.00061	CbGpPWpGaD
Afatinib—ERBB2—Disease—KIT—thymus cancer	0.000246	0.000609	CbGpPWpGaD
Afatinib—EGFR—Signaling by ERBB4—AKT1—thymus cancer	0.000245	0.000607	CbGpPWpGaD
Afatinib—ERBB4—Disease—KIT—thymus cancer	0.000242	0.0006	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.000242	0.000599	CbGpPWpGaD
Afatinib—ABCB1—HIF-1-alpha transcription factor network—AKT1—thymus cancer	0.000241	0.000597	CbGpPWpGaD
Afatinib—LCK—Downstream signaling of activated FGFR—AKT1—thymus cancer	0.00024	0.000595	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.000239	0.000592	CbGpPWpGaD
Afatinib—LCK—Signaling by ERBB4—AKT1—thymus cancer	0.000236	0.000585	CbGpPWpGaD
Afatinib—EGFR—Downstream signal transduction—AKT1—thymus cancer	0.000234	0.00058	CbGpPWpGaD
Afatinib—EGFR—EGF/EGFR Signaling Pathway—AKT1—thymus cancer	0.000233	0.000577	CbGpPWpGaD
Afatinib—EGFR—Signaling by FGFR—AKT1—thymus cancer	0.000233	0.000577	CbGpPWpGaD
Afatinib—EGFR—Signaling by ERBB2—AKT1—thymus cancer	0.000232	0.000574	CbGpPWpGaD
Afatinib—EGFR—DAP12 signaling—AKT1—thymus cancer	0.000231	0.000571	CbGpPWpGaD
Afatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	0.000227	0.000563	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—AKT1—thymus cancer	0.000226	0.00056	CbGpPWpGaD
Afatinib—LCK—Downstream signal transduction—AKT1—thymus cancer	0.000226	0.000559	CbGpPWpGaD
Afatinib—LCK—Signaling by FGFR—AKT1—thymus cancer	0.000224	0.000556	CbGpPWpGaD
Afatinib—LCK—Signaling by ERBB2—AKT1—thymus cancer	0.000223	0.000553	CbGpPWpGaD
Afatinib—LCK—DAP12 signaling—AKT1—thymus cancer	0.000222	0.000551	CbGpPWpGaD
Afatinib—IRAK1—Signaling by NGF—AKT1—thymus cancer	0.000221	0.000548	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—KIT—thymus cancer	0.000221	0.000547	CbGpPWpGaD
Afatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	0.000219	0.000543	CbGpPWpGaD
Afatinib—EGFR—Signaling by FGFR in disease—AKT1—thymus cancer	0.000217	0.000538	CbGpPWpGaD
Afatinib—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000217	0.000538	CbGpPWpGaD
Afatinib—EGFR—DAP12 interactions—AKT1—thymus cancer	0.000217	0.000538	CbGpPWpGaD
Afatinib—EGFR—Signaling by EGFR—AKT1—thymus cancer	0.000215	0.000533	CbGpPWpGaD
Afatinib—EGFR—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.000213	0.000528	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—KIT—thymus cancer	0.000213	0.000527	CbGpPWpGaD
Afatinib—EGFR—Signaling by PDGF—AKT1—thymus cancer	0.000212	0.000526	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—KIT—thymus cancer	0.000212	0.000526	CbGpPWpGaD
Afatinib—LCK—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000209	0.000518	CbGpPWpGaD
Afatinib—LCK—DAP12 interactions—AKT1—thymus cancer	0.000209	0.000518	CbGpPWpGaD
Afatinib—LCK—Signaling by FGFR in disease—AKT1—thymus cancer	0.000209	0.000518	CbGpPWpGaD
Afatinib—LCK—Signaling by EGFR—AKT1—thymus cancer	0.000207	0.000513	CbGpPWpGaD
Afatinib—LCK—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.000205	0.000509	CbGpPWpGaD
Afatinib—EGFR—Focal Adhesion—AKT1—thymus cancer	0.000205	0.000508	CbGpPWpGaD
Afatinib—LCK—Signaling by PDGF—AKT1—thymus cancer	0.000204	0.000507	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—KIT—thymus cancer	0.000204	0.000507	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.000204	0.000506	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CD4—thymus cancer	0.000204	0.000504	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—IL2—thymus cancer	0.000202	0.000501	CbGpPWpGaD
Afatinib—EGFR—B Cell Activation—AKT1—thymus cancer	0.000201	0.000497	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD8A—thymus cancer	0.000201	0.000497	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CD4—thymus cancer	0.000201	0.000497	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—CD4—thymus cancer	0.000198	0.00049	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—AKT1—thymus cancer	0.000197	0.000489	CbGpPWpGaD
Afatinib—LCK—B Cell Activation—AKT1—thymus cancer	0.000193	0.000479	CbGpPWpGaD
Afatinib—BLK—Immune System—CD4—thymus cancer	0.000193	0.000478	CbGpPWpGaD
Afatinib—IRAK1—Immune System—KIT—thymus cancer	0.000192	0.000477	CbGpPWpGaD
Afatinib—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	0.000192	0.000476	CbGpPWpGaD
Afatinib—PHKG2—Disease—AKT1—thymus cancer	0.000189	0.000469	CbGpPWpGaD
Afatinib—ERBB2—Disease—CD4—thymus cancer	0.000188	0.000466	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL2—thymus cancer	0.000187	0.000464	CbGpPWpGaD
Afatinib—LCK—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	0.000185	0.000459	CbGpPWpGaD
Afatinib—ERBB4—Disease—CD4—thymus cancer	0.000185	0.000459	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL2—thymus cancer	0.000184	0.000457	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—MAML2—thymus cancer	0.00018	0.000446	CbGpPWpGaD
Afatinib—BLK—Immune System—IL2—thymus cancer	0.000177	0.00044	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—AKT1—thymus cancer	0.000175	0.000434	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—AKT1—thymus cancer	0.000174	0.000432	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—MAML2—thymus cancer	0.000174	0.00043	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—KIT—thymus cancer	0.000172	0.000426	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—AKT1—thymus cancer	0.000172	0.000426	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD8A—thymus cancer	0.000171	0.000425	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—KIT—thymus cancer	0.000169	0.00042	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—CD4—thymus cancer	0.000169	0.000419	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—AKT1—thymus cancer	0.000167	0.000415	CbGpPWpGaD
Afatinib—LCK—Hemostasis—IL2—thymus cancer	0.000166	0.000412	CbGpPWpGaD
Afatinib—LCK—Immune System—CD8A—thymus cancer	0.000165	0.000409	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—AKT1—thymus cancer	0.000165	0.000409	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—CD4—thymus cancer	0.000163	0.000403	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD4—thymus cancer	0.000162	0.000402	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—AKT1—thymus cancer	0.000159	0.000393	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—AKT1—thymus cancer	0.000158	0.000392	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD4—thymus cancer	0.000156	0.000387	CbGpPWpGaD
Afatinib—ABL1—Immune System—KIT—thymus cancer	0.000151	0.000373	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—AKT1—thymus cancer	0.000148	0.000366	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD4—thymus cancer	0.000147	0.000365	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—AKT1—thymus cancer	0.000142	0.000353	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL2—thymus cancer	0.000135	0.000335	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—TP53—thymus cancer	0.00013	0.000322	CbGpPWpGaD
Afatinib—EGFR—Immune System—KIT—thymus cancer	0.000129	0.000319	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—AKT1—thymus cancer	0.000126	0.000312	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—KIT—thymus cancer	0.000124	0.000308	CbGpPWpGaD
Afatinib—LCK—Immune System—KIT—thymus cancer	0.000124	0.000307	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.000122	0.000302	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL2—thymus cancer	0.000121	0.0003	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL2—thymus cancer	0.000119	0.000296	CbGpPWpGaD
Afatinib—EGFR—Disease—KIT—thymus cancer	0.000119	0.000294	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD4—thymus cancer	0.000115	0.000285	CbGpPWpGaD
Afatinib—LCK—Disease—KIT—thymus cancer	0.000114	0.000284	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—AKT1—thymus cancer	0.000112	0.000277	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—AKT1—thymus cancer	0.00011	0.000271	CbGpPWpGaD
Afatinib—LCK—Hemostasis—TP53—thymus cancer	0.000107	0.000265	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL2—thymus cancer	0.000106	0.000263	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.000103	0.000255	CbGpPWpGaD
Afatinib—ERBB2—Immune System—AKT1—thymus cancer	0.000102	0.000252	CbGpPWpGaD
Afatinib—ERBB4—Immune System—AKT1—thymus cancer	0.0001	0.000248	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL2—thymus cancer	9.91e-05	0.000246	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—AKT1—thymus cancer	9.86e-05	0.000244	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD4—thymus cancer	9.84e-05	0.000244	CbGpPWpGaD
Afatinib—BLK—Immune System—AKT1—thymus cancer	9.62e-05	0.000238	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—AKT1—thymus cancer	9.54e-05	0.000236	CbGpPWpGaD
Afatinib—LCK—Immune System—CD4—thymus cancer	9.48e-05	0.000235	CbGpPWpGaD
Afatinib—ERBB2—Disease—AKT1—thymus cancer	9.38e-05	0.000232	CbGpPWpGaD
Afatinib—ERBB4—Disease—AKT1—thymus cancer	9.24e-05	0.000229	CbGpPWpGaD
Afatinib—EGFR—Disease—CD4—thymus cancer	9.09e-05	0.000225	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL2—thymus cancer	9.05e-05	0.000224	CbGpPWpGaD
Afatinib—LCK—Hemostasis—AKT1—thymus cancer	9.02e-05	0.000224	CbGpPWpGaD
Afatinib—LCK—Disease—CD4—thymus cancer	8.76e-05	0.000217	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL2—thymus cancer	8.75e-05	0.000217	CbGpPWpGaD
Afatinib—LCK—Immune System—IL2—thymus cancer	8.73e-05	0.000216	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—AKT1—thymus cancer	8.43e-05	0.000209	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—KIT—thymus cancer	8.32e-05	0.000206	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—AKT1—thymus cancer	8.12e-05	0.000201	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—AKT1—thymus cancer	8.09e-05	0.000201	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—KIT—thymus cancer	8.02e-05	0.000199	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—AKT1—thymus cancer	7.8e-05	0.000193	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TP53—thymus cancer	7.78e-05	0.000193	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TP53—thymus cancer	7.66e-05	0.00019	CbGpPWpGaD
Afatinib—IRAK1—Immune System—AKT1—thymus cancer	7.34e-05	0.000182	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—AKT1—thymus cancer	6.57e-05	0.000163	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—AKT1—thymus cancer	6.47e-05	0.00016	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL2—thymus cancer	5.85e-05	0.000145	CbGpPWpGaD
Afatinib—ABL1—Immune System—AKT1—thymus cancer	5.75e-05	0.000142	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL2—thymus cancer	5.64e-05	0.00014	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TP53—thymus cancer	5.62e-05	0.000139	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—AKT1—thymus cancer	5.37e-05	0.000133	CbGpPWpGaD
Afatinib—EGFR—Immune System—AKT1—thymus cancer	4.91e-05	0.000122	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—AKT1—thymus cancer	4.75e-05	0.000118	CbGpPWpGaD
Afatinib—LCK—Immune System—AKT1—thymus cancer	4.73e-05	0.000117	CbGpPWpGaD
Afatinib—EGFR—Disease—AKT1—thymus cancer	4.53e-05	0.000112	CbGpPWpGaD
Afatinib—LCK—Disease—AKT1—thymus cancer	4.37e-05	0.000108	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TP53—thymus cancer	3.76e-05	9.31e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TP53—thymus cancer	3.62e-05	8.98e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—AKT1—thymus cancer	3.54e-05	8.78e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—AKT1—thymus cancer	3.17e-05	7.86e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—AKT1—thymus cancer	3.06e-05	7.58e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—AKT1—thymus cancer	1.92e-05	4.75e-05	CbGpPWpGaD
